Limin Xu
- Molecular Biology top 10%
- Cancer Research top 5%
- Renewable Energy, Sustainability and the Environment top 10%
- Materials Chemistry
- Complementary and alternative medicine top 2%
- Topics
- Natural Compounds in Disease Treatment (9 papers)Lipoproteins and Cardiovascular Health (4 papers)MicroRNA in disease regulation (4 papers)
- Cited by
- Cancer ResearchComplementary and alternative medicineRenewable Energy, Sustainability and the Environment
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Limin Xu
52 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Molecular Biology 957
- Cancer Research 343
- Renewable Energy, Sustainability and the Environment 245
- Materials Chemistry 199
- Complementary and alternative medicine 152
Countries citing papers authored by Limin Xu
This map shows the geographic impact of Limin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Xu more than expected).
Fields of papers citing papers by Limin Xu
This network shows the impact of papers produced by Limin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Xu. The network helps show where Limin Xu may publish in the future.
Co-authorship network of co-authors of Limin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Limin Xu. A scholar is included among the top collaborators of Limin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limin Xu. Limin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | Facilitating alkaline hydrogen evolution reaction on the hetero-interfaced Ru/RuO2 through Pt single atoms dopingbreakdown → | 260 |
| 7 | 0 | |
| 8 | 9 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 17 | |
| 12 | 44 | |
| 13 | 34 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 48 | |
| 17 | 72 | |
| 18 | 21 | |
| 19 | 16 | |
| 20 | 20 |
About Limin Xu
Limin Xu is a scholar working on Complementary and alternative medicine, Cancer Research and Molecular Biology, having authored 58 papers that have together received 1.9k indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (343 citations), Complementary and alternative medicine (152 citations) and Renewable Energy, Sustainability and the Environment (245 citations). Limin Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Fanfan Cao, Denghai Zhang, Ruijuan Zhou, Hongzhi Du, Min Liao, Bin Peng, Georges Uzan, Mingming Jin, Liying Cai and Yufeng Jiang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.